NuVasive Receives Latest CE Mark Approval for Pulse Spinal Platform, Begins Global Clinical Evaluations

NuVasive Pulse Integrated Platform

NuVasive announced that the Pulse® platform received CE Mark approval for its latest design update and clinical evaluations are underway in multiple countries throughout Europe.

"The latest CE Mark approval and clinical evaluations are key commercialization milestones for the Pulse platform and further our plan for an expanded global launch...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us